We are live on ! Find out more
TCDA

Tricida, Inc. Common Stock

Delisted

TCDA was delisted on the 23rd of January, 2023.

91 hedge funds and large institutions have $1.56B invested in Tricida, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 53 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

253% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 15

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

31% more capital invested

Capital invested by funds: $1.19B → $1.56B (+$370M)

11% more funds holding

Funds holding: 8291 (+9)

Holders
91
Holders Change
+9
Holders Change %
+10.98%
% of All Funds
1.98%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.13%
New
20
Increased
53
Reduced
15
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$439M +$7.91M +225,000 +2%
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$154M +$56.4M +1,603,231 +70%
BlackRock
3
BlackRock
New York
$93M +$15.7M +447,562 +23%
Vanguard Group
4
Vanguard Group
Pennsylvania
$88.6M +$26M +740,141 +49%
ACA
5
Avoro Capital Advisors
New York
$86.8M +$17.6M +500,000 +29%
BBA
6
Baker Bros. Advisors
New York
$77.7M +$5.86M +166,667 +9%
RG
7
Redmile Group
California
$76.8M +$51.2M +1,454,900 +297%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$57.6M +$13M +368,692 +34%
JP Morgan Chase
9
JP Morgan Chase
New York
$57.3M +$17.1M +486,178 +48%
VC
10
Vivo Capital
California
$56.2M +$22.6M +643,340 +82%
GPP
11
Great Point Partners
Connecticut
$56.2M +$50.1M +1,423,998 New
CAM
12
Cormorant Asset Management
Massachusetts
$46.5M +$5.92M +168,389 +17%
Fidelity Investments
13
Fidelity Investments
Massachusetts
$29.6M -$16.3M -463,800 -38%
Alkeon Capital Management
14
Alkeon Capital Management
New York
$26M +$16.9M +480,000 +268%
State Street
15
State Street
Massachusetts
$18.9M +$5.51M +156,585 +49%
VMI
16
VHCP Management II
New York
$16.9M -$18.8M -533,964 -55%
AG
17
Artal Group
Luxembourg
$14.2M +$4.75M +135,000 +60%
DCM
18
Driehaus Capital Management
Illinois
$13.5M +$2.51M +71,308 +26%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$13.4M +$3.66M +104,193 +44%
GEM
20
Global Endowment Management
North Carolina
$13.1M +$11.7M +333,217 New
Massachusetts Financial Services
21
Massachusetts Financial Services
Massachusetts
$12.5M +$1.71M +48,686 +18%
VMI
22
VHCP Management III
New York
$11.4M -$12.7M -360,839 -55%
Federated Hermes
23
Federated Hermes
Pennsylvania
$10.8M -$5.93M -168,507 -38%
Northern Trust
24
Northern Trust
Illinois
$9.72M +$997K +28,339 +13%
OM
25
Opaleye Management
Massachusetts
$7.7M +$1.06M +30,000 +18%

TCDA Hedge Fund Activity: Q2 2019 in Review

91 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Tricida, Inc. Common Stock (TCDA) for Q2 2019, worth a combined $1.56B — up 31% from $1.19B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TCDA positions and 9 closed out — a net gain of 11 holders — while 53 added to existing stakes and 15 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $56.4M. The largest seller was VHCP Management II, cutting an estimated $18.8M.

  • 91 institutional investors held Tricida, Inc. Common Stock (TCDA) as of Q2 2019, up from 82 in Q1 2019.
  • Funds reported $1.56B of Tricida, Inc. Common Stock stock for Q2 2019, up 31% quarter-over-quarter.
  • 20 funds opened new Tricida, Inc. Common Stock positions in Q2 2019 and 9 closed out, a net change of +11 holders.
  • The largest Tricida, Inc. Common Stock buyer in Q2 2019 was T. Rowe Price Associates, an estimated $56.4M added.
  • The largest Tricida, Inc. Common Stock seller in Q2 2019 was VHCP Management II, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2019.